Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Dormuth, Colin R ^a   Maclure, Malcolm ^b,c   Carney, Greg ^a   Schneeweiss, Sebastian ^d,e   Bassett, Ken ^a   Wright, James M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

^c MINISTRY OF HEALTH   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE;

AGED; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; MALE; MEDICAL RECORD; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; RISK;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; METFORMIN; MIDDLE AGED; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RISK; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 70449717053     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006080     Document Type: Article

References (17)

1. Nissen SE, Wolski K, (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 24: 2457-2471.
2. Singh S, Loke YK, Furberg CD, (2007) Long-term risk of cardiovascular events with rosiglitazone: A meta-analysis. JAMA 298(10): 1189-1195.
3. Lipscombe LL, Gomes T, Levesque LE, Hux JE, Juurlink DN, et al.(2007) Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 298(22): 2634-2643.
4. McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM, (2007) Coronary heart disease outcomes in patients receiving antidiabetic agents. Pharmacoepidemiology 16: 711-725.
5. Diamond GA, Bax L, Kaul S, (2007) Uncertain effects of rosiglitazone on risk of myocardial infarction and cardiovascular death. Ann Intern Med 147: 578-581.
6. Williams JI, Young W, (1996) Inventory of Studies on the Accuracy of Canadian Health Administrative Databases North York, Ontario ICES Publication.
7. Fowles JB, Lawthers AG, Weiner JP, Garnick DW, Petrie DS, et al.(1995) Agreement between physicians' office records and Medicare Part B claims data. Health Care Financ Rev 16: 189-199.
8. Romano PS, Mark DH, (1994) Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 32: 81-90.
9. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J, (1999) Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol 149: 541-549.
10. Fisher ES, Whaley FS, Krushat WM, Malenka DJ, Fleming C, et al.(1992) The accuracy of Medicare's hospital claims data: Progress has been made, but problems remain. Am J Public Health 82: 243-248.
11. BC Health Data Warehouse(2006) http://admin.moh.hnet.bc.ca/hdw, accessed 2006 Dec 22, and reduced by 4% to account for the federally insured. Nursing home residents and social income recipients are included.
12. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, et al.(2004) Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 148(1): 99-104.
13. Romano PS, Roos LL, Jollis JG, (1993) Adapting a clinical comorbidity index for use with ICD-9 CM administrative data: differing perspectives. J Clin Epidemiol 46: 1075-1079.
14. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, et al. Action to Control Cardiovascular Risk in Diabetes Study Group(2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 12;358(24): 2545-2559.
15. University Group Diabetes Program (UGDP)(1970) A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19 (Suppl 2): 747-830.
16. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE, (2007) Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298(10): 1180-1188.
17. Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, et al.(2007) RECORD Study Group. Rosiglitazone Evaluated for Cardiovascular Outcomes - An Interim Analysis. N Engl J Med 357(1): 28-38.